1. Kementrian Kesehatan RI. Situasi dan analisis diabetes. 2014:1-4.

2. Hurel S, Mohan V. Clinical decision making : Managing postprandial hyperglycemia. JAPI.

2006;54.
3. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive
treatment of diabetes on the development and progression of long-term complications in insulin
dependent diabetes mellitus. N Engl J Med 1993; 329(14):977-986.
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in
subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial
infarction. N Engl J Med 1998; 339(4):229-234.
5. Davidson J. Should Postprandial Glucose Be Measured and Treated to a Particular Target? Yes.
Diabetes Care. 2003;26(6):1919-1921.
6. Woerle H, Meyer C, Dostou J, Gosmanov N, Islam N, Popa E et al. Pathways for glucose disposal
after meal ingestion in humans. American Journal of Physiology - Endocrinology And
Metabolism. 2002;284(4):E716-E725.
7. Shrayyef M, Gerich J. Normal Glucose Homeostasis. Principles of Diabetes Mellitus. 2009:19-35.
8. International Diabetes Federation. Guideline for Management of Postmeal Glucose. Brussels;
2007.
9. Arungarinathan G, A McKay G, Fisher M. Drugs for diabetes: part 4 acarbose. Br J Cardiol
[Internet]. 2011 [cited 16 February 2016];18:78−81. Available from: http://bjcardio.co.uk/
10. Perkumpulan Endokrinologi Indonesia. Konsensus Pengolahan dan Pencegahan Diabetes Melitus
Tipe 2 di Indonesia. 2011.
11. Adeghate, Ernest, and Huba Kalász. Amylin Analogues in the Treatment of Diabetes Mellitus:
Medicinal Chemistry and Structural Basis of Its Function.The Open Medicinal Chemistry Journal 5
(2011): 78–81. PMC. Web. 17 Feb. 2016.